Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk Eliem Therapeutics, Inc. per 2025 Jun 30 adalah -52.98 MM.
- Nilai net income untuk Eliem Therapeutics, Inc. per 2025 Jun 30 adalah -46.76 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | -52.98 | -46.76 | |
2025-03-31 | -47.02 | -92.98 | |
2024-12-31 | -27.00 | -73.90 | |
2024-09-30 | -19.17 | -69.12 | |
2024-06-30 | -15.55 | -64.19 | |
2024-03-31 | -16.82 | -14.53 | |
2023-12-31 | -21.47 | -35.12 | |
2023-09-30 | -27.96 | -39.24 | |
2023-06-30 | -31.93 | -44.95 | |
2023-03-31 | -39.65 | -54.33 | |
2022-12-31 | -45.13 | -45.24 | |
2022-09-30 | -46.28 | -48.03 | |
2022-06-30 | -46.92 | -47.96 | |
2022-03-31 | -41.92 | -42.08 | |
2021-12-31 | -35.67 | -47.48 | |
2021-09-30 | -30.92 | -51.80 | |
2021-06-30 | -23.79 | -44.44 | |
2021-03-31 | -16.70 | -37.35 | |
2020-12-31 | -11.77 | -20.67 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | -1.60 | -1.60 |
2024-12-31 | -1.53 | -1.53 |
2024-09-30 | -1.81 | -1.81 |
2024-06-30 | -2.28 | -2.28 |
2024-03-31 | -0.53 | -0.53 |
2023-12-31 | -1.30 | -1.30 |
2023-09-30 | -1.47 | -1.47 |
2023-06-30 | -1.70 | -1.70 |
2023-03-31 | -2.06 | -2.06 |
2022-12-31 | -1.72 | -1.72 |
2022-09-30 | -1.83 | -1.83 |
2022-06-30 | -2.08 | -2.08 |
2022-03-31 | -2.54 | -2.54 |
2021-12-31 | -4.24 | |
2021-09-30 | -8.87 | -8.87 |
2021-06-30 | -16.38 | -16.38 |
2021-03-31 | -15.57 | -15.57 |
2020-12-31 | -10.49 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Eliem Therapeutics, Inc. per 2025 Jun 30 adalah -39.66 MM.
- Nilai cash from investing activities untuk Eliem Therapeutics, Inc. per 2025 Jun 30 adalah -163.16 MM.
- Nilai kas dari aktivitas pendanaan untuk Eliem Therapeutics, Inc. per 2025 Jun 30 adalah 2.31 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | -39.66 | -163.16 | 2.31 |
2025-03-31 | -29.18 | -177.59 | 130.71 |
2024-12-31 | -15.56 | -121.09 | 130.73 |
2024-09-30 | -10.99 | -30.93 | 130.98 |
2024-06-30 | 0.06 | 68.89 | 129.23 |
2024-03-31 | -7.24 | 76.94 | 0.85 |
2023-12-31 | -20.60 | 68.98 | 0.84 |
2023-09-30 | -28.10 | 46.51 | 0.55 |
2023-06-30 | -35.77 | 26.98 | 0.03 |
2023-03-31 | -41.77 | 44.27 | 0.00 |
2022-12-31 | -37.37 | 34.44 | |
2022-09-30 | -36.80 | 12.11 | 0.04 |
2022-06-30 | -45.60 | -103.32 | 83.18 |
2022-03-31 | -40.11 | -119.00 | 143.15 |
2021-12-31 | -36.07 | -114.97 | 177.23 |
2021-09-30 | -33.81 | -98.84 | 182.12 |
2021-06-30 | -23.23 | 8.08 | 98.97 |
2021-03-31 | -18.51 | 8.08 | 39.01 |
2020-12-31 | -14.10 | 8.08 | 4.92 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Eliem Therapeutics, Inc. pada 2025 Jun 30 adalah -3.71.
- p/libro untuk Eliem Therapeutics, Inc. pada 2025 Jun 30 adalah 1.79.
- p/tbv untuk Eliem Therapeutics, Inc. pada 2025 Jun 30 adalah 1.79.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -3.71 | 1.79 | 1.79 |
2025-03-31 | -4.67 | 1.63 | 1.63 |
2024-12-31 | |||
2024-09-30 | -5.20 | 1.50 | 1.50 |
2024-06-30 | -14.55 | 1.99 | 1.99 |
2024-03-31 | 0.69 | 0.69 | |
2023-12-31 | -1.90 | 0.68 | 0.68 |
2023-09-30 | -1.58 | 0.63 | 0.63 |
2023-06-30 | -1.40 | 0.65 | 0.65 |
2023-03-31 | -1.69 | 0.59 | 0.59 |
2022-12-31 | 0.73 | 0.73 | |
2022-09-30 | 0.60 | 0.60 | |
2022-06-30 | -1.89 | 0.51 | 0.51 |
2022-03-31 | -4.67 | 1.33 | 1.33 |
2021-12-31 | -5.32 | 1.56 | 1.56 |
2021-09-30 | -10.66 | 4.65 | 4.65 |
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Eliem Therapeutics, Inc. pada 2025 Jun 30 adalah -0.29.
- EBIT (3 tahun) / EV untuk Eliem Therapeutics, Inc. pada 2025 Jun 30 adalah -0.21.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.29 | -0.21 |
2025-03-31 | -0.29 | -0.18 |
2024-12-31 | ||
2024-09-30 | -0.58 | -0.46 |
2024-06-30 | -0.14 | -0.35 |
2024-03-31 | -2.11 | -2.37 |
2023-12-31 | -2.30 | -2.71 |
2023-09-30 | -0.98 | -1.00 |
2023-06-30 | -1.31 | -1.18 |
2023-03-31 | -1.37 | -1.26 |
2022-12-31 | -0.78 | -0.54 |
2022-09-30 | -0.91 | -0.63 |
2022-06-30 | -0.88 | -0.65 |
2022-03-31 | -0.27 | -0.17 |
2021-12-31 | -0.14 | -0.07 |
2021-09-30 | -0.08 | -0.03 |
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 |
Efektivitas Manajemen
- roa untuk Eliem Therapeutics, Inc. pada 2025 Jun 30 adalah -0.41.
- roe untuk Eliem Therapeutics, Inc. pada 2025 Jun 30 adalah -0.42.
- roic untuk Eliem Therapeutics, Inc. pada 2025 Jun 30 adalah -0.48.
- croic untuk Eliem Therapeutics, Inc. pada 2025 Jun 30 adalah -0.39.
- ocroic untuk Eliem Therapeutics, Inc. pada 2025 Jun 30 adalah -0.15.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.41 | -0.42 | -0.48 | -0.39 | -0.15 |
2025-03-31 | -0.68 | -0.69 | -0.35 | -0.03 | -0.07 |
2024-12-31 | -0.67 | -0.69 | -0.35 | -0.03 | -0.07 |
2024-09-30 | -0.57 | -0.58 | -0.29 | 0.89 | 0.00 |
2024-06-30 | -0.12 | -0.12 | -0.14 | 0.66 | -0.07 |
2024-03-31 | -0.29 | -0.30 | -0.36 | 0.19 | -0.25 |
2023-12-31 | -0.28 | -0.29 | -0.36 | 0.19 | -0.25 |
2023-09-30 | -0.30 | -0.32 | -0.40 | -0.06 | -0.32 |
2023-06-30 | -0.36 | -0.38 | -0.40 | -0.06 | -0.32 |
2023-03-31 | -0.28 | -0.29 | -0.46 | 0.02 | -0.36 |
2022-12-31 | -0.26 | -0.27 | -0.36 | -0.20 | -0.27 |
2022-09-30 | -0.26 | -0.27 | -0.36 | -0.20 | -0.27 |
2022-06-30 | -0.39 | -0.41 | -0.34 | -0.47 | -0.32 |
2022-03-31 | -0.88 | -0.96 | -0.27 | -0.10 | -0.26 |
2021-12-31 | -2.10 | -2.34 | -0.28 | 0.16 | -0.19 |
2021-09-30 | -2.16 | -0.29 | 0.28 | -0.23 | |
2021-06-30 | -2.08 | -2.16 | -0.44 | 0.83 | -0.23 |
2021-03-31 | -1.75 | -1.81 | -0.75 | 0.58 | -0.37 |
2020-12-31 | -0.97 | -1.00 | -0.93 | -0.03 | -0.64 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | |||
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 1768446 |
Grupong Pang-industriya
SIC 2834 - Pharmaceutical Preparations |